- Home
- PNI vs MODD Comparison
PNI vs MODD Comparison
Compare PNI & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNI
- MODD
- Stock Information
- Founded
- PNI 2002
- MODD 1998
- Country
- PNI United States
- MODD United States
- Employees
- PNI N/A
- MODD 40
- Industry
- PNI Trusts Except Educational Religious and Charitable
- MODD Industrial Specialties
- Sector
- PNI Finance
- MODD Health Care
- Exchange
- PNI Nasdaq
- MODD Nasdaq
- Market Cap
- PNI 82.8M
- MODD 67.4M
- IPO Year
- PNI N/A
- MODD N/A
- Fundamental
- Price
- PNI $7.41
- MODD $2.07
- Analyst Decision
- PNI
- MODD Buy
- Analyst Count
- PNI 0
- MODD 1
- Target Price
- PNI N/A
- MODD $5.00
- AVG Volume (30 Days)
- PNI 26.4K
- MODD 98.7K
- Earning Date
- PNI 01-01-0001
- MODD 11-26-2024
- Dividend Yield
- PNI 4.76%
- MODD N/A
- EPS Growth
- PNI N/A
- MODD N/A
- EPS
- PNI N/A
- MODD N/A
- Revenue
- PNI N/A
- MODD N/A
- Revenue This Year
- PNI N/A
- MODD N/A
- Revenue Next Year
- PNI N/A
- MODD $830.43
- P/E Ratio
- PNI N/A
- MODD N/A
- Revenue Growth
- PNI N/A
- MODD N/A
- 52 Week Low
- PNI $6.03
- MODD $1.00
- 52 Week High
- PNI $7.89
- MODD $2.65
- Technical
- Relative Strength Index (RSI)
- PNI 42.48
- MODD 38.24
- Support Level
- PNI $7.27
- MODD $2.15
- Resistance Level
- PNI $7.54
- MODD $2.34
- Average True Range (ATR)
- PNI 0.07
- MODD 0.12
- MACD
- PNI 0.01
- MODD -0.02
- Stochastic Oscillator
- PNI 50.00
- MODD 6.25
About PNI Pimco New York Municipal Income Fund II of Beneficial Interest
PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.